Spiro (furo [3, 2-C] pyridine-3-3 ' -indol) -2' (1'H)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain

Details for Australian Patent Application No. 2007307638 (hide)

Owner Xenon Pharmaceuticals Inc.

Inventors Liu, Shifeng; Sun, Jianyu; Kamboj, Rajender; Chowdhury, Sultan; Cadieux, Jean-Jacques; Hsieh, Tom; Jia, Qi; Fu, Jianmin

Agent Davies Collison Cave

Pub. Number AU-A-2007307638

PCT Pub. Number WO2008/046049

Priority 60/851,237 12.10.06 US; 60/955,582 13.08.07 US

Filing date 12 October 2007

Wipo publication date 17 April 2008

International Classifications

C07D 471/20 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4747 (2006.01) - spiro-condensed

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/046049 Priority application(s): WO2008/046049

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007307639-Method and apparatus for occluding a lumen

2007307635-Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents